Zhang Hong, Wang Yue-Shu, Han Gang, Shi Ying
Department of General Surgery, Second Hospital of Jilin University, Changchun 130041, China.
Hepatobiliary Pancreat Dis Int. 2007 Oct;6(5):487-91.
Tissue inhibitor of metalloproteinases (TIMPs) can restrain the tumor growth by their protein property and matrix metalloproteinases (MMPs) inhibition. There are currently four known TIMP family members-TIMP-1, 2, 3, 4. We determined whether increasing levels of TIMP-3 expression could suppress the malignant phenotype of human hepatocarcinoma cell line HCC-7721.
A recombinant expression vector, which contained full-length cDNA of human TIMP-3, was constructed and transfected into the human hepatocarcinoma cell line HCC-7721 by the lipofectamine technique. In vitro and in vivo tests such as Western blotting, immunohistochemistry as well as xenografting in nude mice were used to analyze expression levels of TIMP and MMP, and changes in malignant phenotype after the gene transfection.
TIMP-3 expression in TIMP-3 gene-transfected HCC-7721 cells was upregulated as assessed by Western blotting. The ability of in vitro invasion through a Boyden chamber was significantly decreased compared to controls. Following subcutaneous injection into nude mice, the TIMP-3 transfected cells suppressed primary tumor growth, as characterized by reduced tumor weight, size and microvasculature as well as maintaining the extracellular matrix.
The results suggest that upregulation of TIMP-3 expression in HCC-7721 cells inhibits invasion capacity in vitro as well as tumorigenic and metastatic potential in nude mice.
金属蛋白酶组织抑制剂(TIMPs)可通过其蛋白质特性和抑制基质金属蛋白酶(MMPs)来抑制肿瘤生长。目前已知TIMPs家族有四个成员——TIMP-1、2、3、4。我们研究了提高TIMP-3表达水平是否能抑制人肝癌细胞系HCC-7721的恶性表型。
构建含有人TIMP-3全长cDNA的重组表达载体,通过脂质体技术转染人肝癌细胞系HCC-7721。采用蛋白质印迹法、免疫组织化学法以及裸鼠异种移植等体内外实验,分析基因转染后TIMP和MMP的表达水平以及恶性表型的变化。
通过蛋白质印迹法评估,TIMP-3基因转染的HCC-7721细胞中TIMP-3表达上调。与对照组相比,其通过博伊登小室的体外侵袭能力显著降低。皮下注射到裸鼠体内后,TIMP-3转染细胞抑制了原发性肿瘤生长,表现为肿瘤重量、大小和微血管减少以及细胞外基质得以维持。
结果表明,HCC-7721细胞中TIMP-3表达上调可抑制其体外侵袭能力以及裸鼠体内的致瘤和转移潜能。